Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06300242 · ClinicalTrials.gov registry record · NA
Incentives for Influenza Vaccination
A NA study of Influenza Vaccination, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 69,972
- Enrollment target
- 1
- Study location
NCT06300242 is a NA study of Influenza Vaccination that has completed, run by University of Southern California. The registered enrollment target is 69,972 participants, above the 14,550-participant average among 3 other Influenza Vaccination trials with a reported enrollment target (381% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06300242, a NA study of Influenza Vaccination, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 69,972 participants
- Enrollment target
- 1
- Study location
Study Summary
In this work, we are assessing the impact of messaging with or without a $50 financial incentive on influenza vaccination rates in a county health system. Our main hypothesis is that a message with a $50 financial incentive will increase vaccination rates relative to a control/"treatment as usual" group. We further hypothesize that the financial incentive will increase vaccination rates relative to the message only arm.
Conditions Studied
Interventions
- OTHER Placebo
- BEHAVIORAL Reminders
- BEHAVIORAL Financial Incentive
Study Locations (1)
California
- Contra Costa Health Services - Martinez
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69,972 participants |
| Start Date | 2024-01-17 |
| Est. Completion | 2024-02-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06300242
The ClinicalTrials.gov registry entry for NCT06300242 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69,972 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 14,550-participant average among 3 other Influenza Vaccination trials with a reported enrollment target (381% higher). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Influenza Vaccination appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06300242 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06300242 about?
NCT06300242 is a clinical study titled "Incentives for Influenza Vaccination". In this work, we are assessing the impact of messaging with or without a $50 financial incentive on influenza vaccination rates in a county health system. Our main hypothesis is that a message with a $50 financial incentive will increase vaccination rates relative to a control/"treatment as usual" g...
What is the current status of trial NCT06300242?
This trial is currently completed. It is a NA study. The enrollment target is 69,972 participants. The study started on 2024-01-17. Estimated completion is 2024-02-29.
What conditions does trial NCT06300242 study?
This clinical trial studies the following conditions: Influenza Vaccination.
What interventions are being tested in trial NCT06300242?
The interventions under investigation include: Placebo (OTHER), Reminders (BEHAVIORAL), Financial Incentive (BEHAVIORAL).
Who is sponsoring clinical trial NCT06300242?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06300242 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.